Trials with Maya Z

Trials with Maya Z

Maya Zlatanova
Country USA
Language EN
Episodes 54
Latest 13.07.2026

This podcast explores the world of clinical trials, focusing on why 90% of trials fail and 85% get delayed. Host Maya Zlatanova, CEO of TrialHub, interviews passionate industry experts to uncover what makes trials more successful or challenging. Each episode dives into the planning and execution of clinical research, offering insights from experienced professionals. The goal is to understand the factors that impact trial outcomes and improve future studies.

Episodes

  • The Transparency Mindset: Why Clinical Trial Results Still Go Missing with Andrew Freeman
    The Transparency Mindset: Why Clinical Trial Results Still Go Missing with Andrew Freeman 13.07.2026 44m
    Andrew Freeman spent over two decades at GSK, where he led the company's efforts on clinical trial transparency - trial registration, results reporting, and sharing patient-level data with researchers. Yet when his own father was diagnosed with late-stage cancer, he couldn't find him a trial through clinicaltrials.gov. He gave up and found one through a personal contact instead. As Andrew puts it, that shouldn't be the way it works.Andrew was at the WHO meeting in Geneva where the 20 or so data elements for study registration were identified, and since the end of 2022 he chairs the board of IS...
  • The Value of Early Access Programs With Naomi Litchfield
    The Value of Early Access Programs With Naomi Litchfield 23.03.2026 24m
    Naomi Litchfield’s passion for Early Access Programs (EAPs) stems from a personal experience - her sister’s life was saved by an early access drug after being diagnosed with four rare cancers. With nearly 20 years of industry experience, Naomi is now the Director Patient Advocacy at Bionical Emas.In this episode, Naomi and Maya discuss: • What Early Access Programs are and how they work • How EAPs provide hope and open doors for patients in need • The challenges and considerations involved in setting up an EAPEarly Access Resources:https://bionicalemas.com/resources/johnson-johnson-guide-to-ex...
  • The Power of Innovative Trial Designs with Philip Raeth
    The Power of Innovative Trial Designs with Philip Raeth 18.03.2025 31m
    Clinical trials are evolving, but are we innovating fast enough? In this episode Maya sits down with Philip Raeth from Palleos Healthcare to explore how new trial designs can challenge the status quo. From adaptive methodologies to efficiency-driven models, we discuss how rethinking trial structure can help us tackle industry-wide hurdles—not just in patient recruitment and retention, but in trial execution, costs, and outcomes. What does the future of clinical trials look like? Tune in as we brainstorm new possibilities.Follow Philip Raeth: https://www.linkedin.com/in/philip-raeth-51911114/Fo...
  • How to get from Sick Care to Health Care and Rethinking Pharma’s Role with Paul Simms
    How to get from Sick Care to Health Care and Rethinking Pharma’s Role with Paul Simms 31.01.2025 36m
    Paul Simms is the CEO of Impatient Health and a trailblazing voice in the life sciences industry. Paul is on a mission to push the boundaries of pharma. He works with innovators and early adopters to inject “mutation pressure” into the status quo, ensuring bold ideas and creative solutions make their way into the market. Drawing on his experience as a speaker, event organizer, and consultant, Paul discusses how pharma can evolve to truly align with patients’ needs. Together, with Maya they explore the intersection of innovation, behavioral science, and systemic transformation in healthcare.Wha...
  • Patient Engagement and Standard of Care in Rare Disease Trials with Orit Rindner
    Patient Engagement and Standard of Care in Rare Disease Trials with Orit Rindner 10.12.2024 18m
    In this episode of Trials with Maya Z, Maya and patient expert and advocate Orit Rindner discuss the intersection of patient needs and clinical trials, highlighting real-world challenges and insights from rare disease research:The impact of standard of care on patient willingness to join clinical trialsChallenges in rare disease trials and patient recruitmentThe importance of aligning clinical trials with patient realitiesFollow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/Follow Orit Rindner: https://www.linkedin.com/in/oritrindner/ (00:00) - Chapter 1 (00:00) - Introduction to C...
  • Endometriosis: Why Standard Care Isn't Cutting It - Exploring the Gaps with Estelle Jobson
    Endometriosis: Why Standard Care Isn't Cutting It - Exploring the Gaps with Estelle Jobson 26.11.2024 39m
    "Only 1-4% of global healthcare R&D funding is dedicated to female-specific conditions beyond cancer, despite women representing 51% of the population.” Meet Estelle Jobson - an EUPATI Fellow and a patient advocate living with endometriosis. In this episode, Maya and Estelle discuss the limitations of standard care for this chronic condition and call for research that addresses its diverse symptoms. Why Standard care for endometriosis fails to address patient needs?What is wrong with the current definition of endometriosis?What are the current treatment gaps?Follow Maya Zlatanova: https://www....
  • RWD Data and Trust in Clinical Trials: Ritesh Patel’s Take
    RWD Data and Trust in Clinical Trials: Ritesh Patel’s Take 19.11.2024 30m
    Join Maya Zlatanova and Ritesh Patel from Finn Partners as they dive into the evolving world of real-world data in clinical trials. Discover the challenges of integrating diverse patient data, the role of social determinants in trial outcomes, and how emerging technologies like AI and digital biomarkers are set to revolutionize the industry. Packed with insights on collaboration and innovation, this episode is a must-listen for anyone passionate about transforming healthcare through data-driven strategies.Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/Follow Ritesh Patel: htt...
  • The patient journey in US vs EU and how involving patients early on can help with Ella Balasa
    The patient journey in US vs EU and how involving patients early on can help with Ella Balasa 14.11.2024 26m
    Ella Balasa has experience on both sides of the research spectrum - as a patient with cystic fibrosis and as a scientist examining antibiotic-resistant bacteria. She is on a mission to amplify patient voices in drug development. In this episode Ella and Maya discuss:Ella’s journey and advising experienceThe difference in the patient journey in US vs. EuropeThe often overlooked challenges in patient access to careFollow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/Follow Ella Balasa: https://www.linkedin.com/in/ella-balasa/
  • Real-world data: The Good, the Bad and the Ugly with Jan Poleszczuk from CliniNote
    Real-world data: The Good, the Bad and the Ugly with Jan Poleszczuk from CliniNote 29.10.2024 22m
    Meet Jan Poleszczuk, a mathematician turned healthcare innovator and a CTO of CliniNote. In this episode Maya and Jan talk about:- The top 3 challenges hindering the quality of RWD- How CliniNote is helping doctors generate quality data while simplifying their workflow- The potential of RWD in clinical trials Tune in to explore the good, the bad, and the ugly of Real-World Data and how innovators like Jan Poleszczuk are working to unlock its full potential to improve patient care and drive healthcare innovation.Follow Maya on LinkedIn: https://www.linkedin.com/in/mayazlatanova/ Follow Jan on L...
  • Understanding the Patient Journey is Our Duty as Researchers: Esther Howard's Insights from Two Decades in Clinical Research
    Understanding the Patient Journey is Our Duty as Researchers: Esther Howard's Insights from Two Decades in Clinical Research 22.10.2024 33m
    Meet Esther Howard, Mental Health Advocate, Researcher and CEO of Bezyl. In this conversation, Esther shares her unique perspective on the importance of understanding patient journey, not just as a scientific necessity, but as a fundamental human duty for researchers. Esther explores the three critical prongs of patient journey: standard of care, the specifics of the patient's disease, and the often-overlooked aspects of their daily lives. She emphasizes the need for researchers to look beyond the protocol and embrace a more holistic view of patients' experiences, arguing that by embracing our...
  • Connecting the Dots in The Patient Journey - The Importance Of Patient Trust with Heidi Floyd
    Connecting the Dots in The Patient Journey - The Importance Of Patient Trust with Heidi Floyd 15.10.2024 20m
    Meet Heidi Floyd, a breast cancer survivor, patient advocate, and champion for transforming clinical trials through authentic patient engagement. In this powerful episode, Heidi shares her remarkable journey of navigating cancer treatment while pregnant.Heidi emphasizes the critical importance of building meaningful relationships between patients, healthcare providers, and clinical trial teams. She discusses the common reasons patients may choose to quit clinical trials and the need for greater understanding and support of patient circumstances.Follow Maya Zlatanova: https://www.linkedin.com/i...
  • Building the Batman Belt: Leveraging Data and Standard of Care in Trials with Travis Caudill
    Building the Batman Belt: Leveraging Data and Standard of Care in Trials with Travis Caudill 08.10.2024 41m
    Meet Travis Caudill, Vice President of Feasibility and Clinical Informatics at ICON, a seasoned expert in the world of clinical trial optimization. Discover how Travis and his team are navigating the complexities of trial feasibility—using data to optimize site selection, understanding local patient journeys, and anticipating changes in the standard of care. Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/Follow Travis Caudill: https://www.linkedin.com/in/feasibility/ (00:00) - Introduction and Background (04:34) - The Access to Data and Tools for Analysis (08:57) - The Focus...
  • How To Prevent Clinical Trial Nightmares With Ilknur Lechthaler
    How To Prevent Clinical Trial Nightmares With Ilknur Lechthaler 01.10.2024 22m
    Ilknur Lechthaler is an expert in clinical operations, research, and startup investments. Ilknur discusses how the industry's awareness of the significance of country-specific standard of care has evolved over the past decade. Together with Maya they dive into the practical aspects of country selection and the factors that influence decision-making, such as regulatory requirements, timelines, and budget constraints. Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/Follow Ilknur Lechthaler: https://www.linkedin.com/in/ilknur-lechthaler/
  • Mapping the Patient Journey: Roadmap to Successful Trial Design with Todd Georgieff
    Mapping the Patient Journey: Roadmap to Successful Trial Design with Todd Georgieff 24.09.2024 42m
    Meet Todd Georgieff - a veteran in drug development and clinical operations with expertise in optimizing global trials. In this episode, Todd and Maya explore the critical aspects of protocol optimization and patient burden quantification. How does understanding local standard of care impact trial success? What are the ethical implications of providing treatments in different healthcare systems? Todd shares insights on these questions and more.Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/Follow Todd Georgieff: https://www.linkedin.com/in/toddgeorgieff/ (00:00) - Introductio...
  • How Access to Treatments Impacts Trials: From Protocol Development, to Country and Site Selection with Kasia Harris
    How Access to Treatments Impacts Trials: From Protocol Development, to Country and Site Selection with Kasia Harris 17.09.2024 32m
    Meet Kasia Harris - an expert in clinical trial feasibility and planning with experience in both CRO and Pharma. bringing valuable insights into the complexities of global healthcare systems. In this episode, Kasia and Maya delve into the critical role of understanding local standard of care in clinical trial success. They explore feasibility assessments, protocol, country, and site-specific considerations. Kasia highlights how standard of care impacts patient enrollment, country and site selection, and overall trial efficiency. This episode is a must listen for anyone involved in planning or...
  • Viagra's Hard Lessons: Why Understanding the Patient Journey is Non-Negotiable with Annabel de Maria Bosch
    Viagra's Hard Lessons: Why Understanding the Patient Journey is Non-Negotiable with Annabel de Maria Bosch 10.09.2024 33m
    Meet Annabel de Maria Bosch - the Chief Patient Officer at Alira Health with nearly three decades of experience in patient engagement across the pharmaceutical industry. In this insightful conversation, Annabel shares her unique perspective on the critical importance of understanding the patient journey and its impact on clinical trial success. Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/Follow Annabel de Maria Bosch: https://www.linkedin.com/in/annabeldemaria/Annabel shares some very curious studies in the episode:1)Stergiopoulos et al., Measuring the Impact of Patient En...
  • From Carer to Catalyst: Joy Milne's Journey to Revolutionize Parkinson's Research
    From Carer to Catalyst: Joy Milne's Journey to Revolutionize Parkinson's Research 05.09.2024 30m
    Meet Joy Milne, a remarkable woman whose unique sense of smell is revolutionizing the world of Parkinson's research. In this episode, Joy shares her personal story of love, loss, and unwavering determination to make a difference in the lives of those affected by Parkinson's, from her groundbreaking work with researchers at the University of Manchester to her advocacy for greater awareness of the challenges faced by women with the disease. Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/Learn more about Joy Milne and her work:https://www.nytimes.com/2024/06/14/magazine/parkinso...
  • The true cost of patient acquisition and the ever-rising site burden with Ted Trafford
    The true cost of patient acquisition and the ever-rising site burden with Ted Trafford 03.09.2024 28m
    Meet Ted Trafford - a seasoned clinical research expert with nearly three decades of experience and a passion for driving innovation in the industry. As the Director of Business Development at Probity Medical Research, Ted brings unique insights into the challenges faced by sites, sponsors, and patients in the clinical trial landscape.Follow Maya Zlatanova: https://www.linkedin.com/in/mayazlatanova/Follow Ted Trafford: https://www.linkedin.com/in/tedtrafford/Check out Ted's post mentioned in the episode: https://www.linkedin.com/posts/tedtrafford_clinical-trial-marathon-activity-72218411569580...
  • Fail-Proofing Clinical Trials: Lessons in Smart Planning with Angie Schwab
    Fail-Proofing Clinical Trials: Lessons in Smart Planning with Angie Schwab 26.08.2024 33m
    Meet Angie Schwab - founder of EZ Research Solutions and a passionate expert in clinical research with a focus on improving trial startup processes. In this episode, Angie and Maya dive deep into the challenges and solutions in clinical trial design and execution. Angie shares her insights on the critical importance of thorough planning, understanding local standards of care, and involving all stakeholders - including patients - in study design. They explore how poor initial planning can set trials up for failure and discuss innovative solutions, including the role of automation and AI in stre...
  • Small Patients, Big Challenges: Obstacles in Paediatric Rare Disease Research with Begonya Nafria
    Small Patients, Big Challenges: Obstacles in Paediatric Rare Disease Research with Begonya Nafria 22.08.2024 34m
    Meet Begonya Nafria - Head of the Patient Engagement in Research Department at Hospital Sant Juan de Déu Children’s Hospital, championing the cause of paediatric clinical research. In this eye-opening episode, Begonya and Maya delve into the unique challenges of conducting clinical trials for children, especially those with rare diseases. Begonya highlights the startling fact that 95% of rare diseases have no approved treatment, emphasizing the urgent need for increased research investment and improved access to cross-border clinical trials for children and young patients in Europe . This conv...

Popular in

The podcast also appears in the podcast charts of these countries.